• Prochlorperazine: Dopamine D2 Antagonist in Melanoma Researc

  2026-05-17

  Prochlorperazine’s profile as a dopamine D2 receptor antagonist unlocks advanced applications in antiemetic therapy and melanoma research. Explore how workflows that leverage its unique pharmacology—ranging from cell migration assays to antiviral screens—can be optimized for reproducibility, sensitivity, and translational relevance.

• PNU 74654: Wnt Signaling Pathway Inhibitor for Cell Modulati

  2026-05-16

  PNU 74654 is a high-purity small molecule Wnt signaling pathway inhibitor developed by APExBIO. It selectively impedes the Wnt/β-catenin signaling cascade, critical for cell proliferation and differentiation studies. This dossier defines its mechanism, evidence base, and research boundaries.

• Host Actin–Myosin II Network Regulates Duck Enteritis Virus

  2026-05-15

  This study uses proteomic screening to reveal that the duck enteritis virus (DEV) protein VP26 interacts with host cytoskeletal proteins, particularly the actin–myosin II network, to facilitate viral proliferation. The findings highlight how disruption of actin polymerization significantly reduces viral titers, offering mechanistic insight into host–pathogen interactions and experimental strategies for cytoskeleton-targeted research.

• Recombinant Annexin V Expression: Enabling Sensitive Apoptos

  2026-05-15

  This study details a high-yield protocol for expressing and purifying recombinant annexin V in E. coli, facilitating reliable detection of apoptotic membrane changes via phosphatidylserine externalization. The described methods enhance quantitative apoptosis assays and set a technical foundation for membrane biology research.

• Rhodamine B in Drift Analysis & Cell Labeling: Protocols & I

  2026-05-14

  Rhodamine B (Basic Violet 10) bridges environmental drift tracing and advanced cell labeling, thanks to its high solubility and robust fluorescence. This article decodes experimental workflows and troubleshooting strategies for maximizing Rhodamine B's value from UAV pesticide drift studies to sensitive fluorescence microscopy.

• HCN4 Channels Mediate Cardiac Heat Response via S4-S5 Motif

  2026-05-14

  This study uncovers a conserved motif in cardiac HCN4 channels essential for heart rate acceleration in response to heat. The findings clarify the molecular basis of thermal heart rate regulation and highlight new opportunities for mechanistic exploration in cardiac physiology.

• Talabostat Mesylate: Systems-Level Insights for Tumor Microe

  2026-05-13

  Explore how Talabostat mesylate (PT-100) enables systems-level modulation of the tumor microenvironment through precise DPP4 and FAP inhibition. This article uniquely integrates multidimensional RNA-seq insights and practical assay parameters for advanced cancer research.

• Clozapine N-oxide: Precision Chemogenetics in Neuroscience R

  2026-05-13

  Clozapine N-oxide (CNO) empowers researchers to precisely modulate neuronal circuits using chemogenetic approaches, enabling robust, reversible control in both basic and translational neuroscience. This guide details optimized workflows, experimental advances, and troubleshooting strategies to maximize reliability and reproducibility with APExBIO’s high-purity CNO.

• Fludarabine: DNA Synthesis Inhibitor for Oncology Workflows

  2026-05-12

  Fludarabine, a validated DNA synthesis inhibitor from APExBIO, enables reproducible apoptosis induction and cell cycle arrest in leukemia and multiple myeloma research. This guide details experimental workflows, troubleshooting strategies, and protocol parameters to maximize Fludarabine’s impact in both in vitro and in vivo oncology models.

• 5-Methyl-CTP: Advancing mRNA Stability and Translation Effic

  2026-05-12

  5-Methyl-CTP, a 5-methyl modified cytidine triphosphate from APExBIO, is redefining mRNA synthesis by enhancing transcript stability and translation efficiency. Its integration into in vitro transcription workflows streamlines the production of robust mRNAs for gene expression research and next-generation mRNA vaccine development.

• Nintedanib (BIBF 1120): Triple Angiokinase Inhibitor Benchma

  2026-05-11

  Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor targeting VEGFR, FGFR, and PDGFR pathways, with nanomolar efficacy in cancer and fibrosis models. Its antiangiogenic and antifibrotic activity is supported by robust preclinical and clinical data.

• Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP): Unraveling Immu

  2026-05-11

  Discover how Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) enables precise gene expression, superior stability, and low immunogenicity for advanced bioluminescent reporter and cell viability assays. This article explores unique immunological insights and practical protocol optimizations for reproducible, high-sensitivity assays.

• Cytoskeleton-Dependent Autophagy Under Mechanical Stress

  2026-05-10

  This study provides direct evidence that the cytoskeleton—especially microfilaments—plays a central role in mediating autophagy triggered by mechanical compression in human cells. By dissecting the distinct contributions of microfilaments and microtubules, the research advances our understanding of mechanotransduction pathways and opens new avenues for investigating calcium signaling and cellular stress responses.

• Penicillin G Sodium in Barrier Integrity: Precision Antibios

  2026-05-09

  Explore the advanced applications of Penicillin G Sodium, a natural penicillin antibiotic, in safeguarding cellular barriers and optimizing infection models. This article delivers a unique, in-depth analysis of its role in bacterial cell wall biosynthesis inhibition and barrier integrity, setting it apart from conventional content.

• I-BET151 (GSK1210151A): Selective BET Inhibition in Cancer R

  2026-05-08

  I-BET151 (GSK1210151A) is a potent, selective BET bromodomain inhibitor targeting BRD2, BRD3, and BRD4, validated for modulating transcriptional programs in cancer biology. The compound supports robust apoptosis and cell cycle arrest assays, with demonstrated efficacy in MLL-fusion leukemia and glioblastoma models. Evidence underscores its role in dissecting super-enhancer-driven oncogenic pathways and programmed cell death mechanisms.

16151 records 7/1077 page Previous Next First page 上5页 678910 下5页 Last page